The Latest Breaking News from Pfizer

Novavax Inc.’s shares surged after its COVID-19 vaccine won backing from a panel of U.S. public health advisers, a crucial step in providing officials with another tool against the virus as cases start to rise again.

Two-dose shot will becomes fourth one to gain full approval later this week

Government advisers say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax

Patients with prescriptions for antiviral drugs after catching COVID-19 are struggling to get them filled at pharmacies across Queensland, a medical association says, as increased illegibility increases demand on stocks.

How Sotiris Missailidis, head of R&D in Brazil's vaccine agency, used the COVID crisis to push through a game-changing effort for middle-income countries to invent their own mRNA vaccine.

‘Continual updating of our vaccinations and booster shots is critical,’ scientists say

Australia has used less than a quarter of the hundreds of millions of COVID-19 vaccine doses it bought. What will happen to the rest?

ORLANDO, Fla. — Scientists have suggested that once vaccines and treatment for COVID-19 became widely available, a surge might not require more than the basic precautions practiced during flu season. With the development of vaccines, pre-exposure treatment such as Evushield and post-exposure treatment such as Paxlovid, it’s natural to ask…

After over two years of COVID-19-induced lockdown, Bhutan will open its doors for tourists on September 23 with a new expensive policy for international tourists and Indians as well. Bhutan Foreign Minister Tandi Dorji says the lessons of COVID-19 include better ties with neighbours, including China.

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 16 strange trades.

ATLANTA — Sesame Street’s Elmo, who is 3½, recently got his COVID-19 vaccine.